Patent details

Basic Information

Publication number:

EP1874306

PCT Application Number:

PCT/US/2006/012887

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP067494393

PCT Publication Number:

WO/2006/110483

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

COMPOSITIONS OF AN ORALLY ACTIVE 1,2,4-OXADIAZOLE FOR NONSENSE MUTATION SUPPRESSION THERAPY

French Title of Invention:

COMPOSITIONS DE 1,2,4-OXADIAZOLE ORALEMENT ACTIVES POUR UN TRAITEMENT DE SUPPRESSION DE MUTATIONS NON-SENS

German Title of Invention:

ZUSAMMENSETZUNGEN AUS EINEM ORAL WIRKSAMEN 1,2,4-OXADIAZOL FÜR DIE NONSENSE-MUTATIONS-SUPPRESSIONSTHERAPIE

SPC Number:

Dates

Filing date:

06/04/2006

Grant date:

04/07/2012

EP Publication Date:

04/07/2012

PCT Publication Date:

19/10/2006

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

09/01/2008

EP B1 Publication Date:

04/07/2012

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

06/04/2013

Expiration date:

06/04/2026

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

06/04/2006

 

 

Name:

PTC Therapeutics Inc.

Address:

100 Corporate Court, Middlesex Business Center, South Plainfield, NJ 07080, United States (US)

Inventor

1

Name:

MILLER Langdon

Address:

United States (US)

2

Name:

HIRAWAT Samit

Address:

United States (US)

Priority

1

Priority Number:

669789 P

Priority Date:

08/04/2005

Priority Country:

United States (US)

2

Priority Number:

787395 P

Priority Date:

30/03/2006

Priority Country:

United States (US)

Classification

Main IPC Class:

A61K 31/4245;

Filing date	Document type	Number of pages